ESMO 2021 treatment advances in muscle-invasive bladder cancer, muscle-invasive bladder cancer, the role of chemotherapy in muscle-invasive bladder cancer, adjuvant chemotherapy for muscle-invasive bladder cancer, neoadjuvant setting muscle-invasive bladder cancer,
ESMO 2021 enhanced androgen signaling inhibition or docetaxel for treatment of metastatic castration sensitive prostate cancer (mCSPC), use of docetaxel, CHAARTED trial, STAMPEDE trial, ARCHES, trial, ENZAMET trial, TITAN trial.